Austin, April 14, 2025 (GLOBE NEWSWIRE) -- Comprehensive Metabolic Panel Testing Market Size & Growth Analysis: According to a new report by SNS Insider, the Comprehensive Metabolic Panel (CMP) ...

San Francisco, USA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The Pan-Genomic and Multi-Gene Panel Testing Market reached a valuation of US$ 8,907.34 million in 2024 and is projected to grow steadily over the ...

Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (DPYD) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer Center Of the 582 surveys sent, ...

The CMP testing market is fueled by increasing awareness of preventive healthcare and early detection of metabolic disorders. Chronic conditions such as diabetes, kidney diseases, and liver ailments, ...

Implementation of Cancer Genomics in the United States: Views of Payers and Other Stakeholders on Challenges and the Role of Payers in Solutions We matched 147 multigene panel patients to controls, ...

Germline genetic testing identifies pathogenic variants present at birth that increase the risk of developing ovarian cancer. It also identifies the risk of developing other cancers and, for adults ...